Audet & Partners, LLP reports that a judge in Pennsylvania overseeing hundreds of Risperdal lawsuits has ruled that the plaintiffs in these lawsuits will be barred under New Jersey law from asserting claims for punitive damages. This[...]
Archive
Tag: Janssen Pharmaceuticals
Plaintiffs in consolidated Risperdal lawsuits now pending in Pennsylvania have argued that a New Jersey statute barring punitive damages in lawsuits brought involving FDA-approved drugs does not apply when the injuries alleged result from off-label or[...]
Janssen Pharmaceuticals, a division of Johnson & Johnson that manufactured and marketed the antipsychotic drug Risperdal to adolescent males, asked a Pennsylvania court in a Motion for Summary Judgment dated May 19, 2014, to hold that[...]
On March 20, 2014, the Arkansas Supreme Court overturned a trial court award of $1.2 billion to the State of Arkansas against Johnson & Johnson, and its Janssen Pharmaceuticals, Inc. division based on the company's marketing[...]